173 related articles for article (PubMed ID: 30982500)
1. C-terminal truncated HBx reduces doxorubicin cytotoxicity via ABCB1 upregulation in Huh-7 hepatocellular carcinoma cells.
Jegal ME; Jung SY; Han YS; Kim YJ
BMB Rep; 2019 May; 52(5):330-335. PubMed ID: 30982500
[TBL] [Abstract][Full Text] [Related]
2. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
3. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
Ng KY; Chai S; Tong M; Guan XY; Lin CH; Ching YP; Xie D; Cheng AS; Ma S
Oncotarget; 2016 Apr; 7(17):24005-17. PubMed ID: 27006468
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells.
Wang W; Zhou D; Wei J; Wu Z; Cheng X; Sun Q; Xie H; Zhou L; Zheng S
Biochem Biophys Res Commun; 2012 May; 421(2):355-60. PubMed ID: 22510407
[TBL] [Abstract][Full Text] [Related]
5. C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.
Sze KM; Chu GK; Lee JM; Ng IO
Hepatology; 2013 Jan; 57(1):131-9. PubMed ID: 22821423
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1.
Yang Y; Zhang J; Wu T; Xu X; Cao G; Li H; Chen X
Life Sci; 2019 Jan; 216():200-206. PubMed ID: 30465789
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence.
Huang P; Zhuang B; Zhang H; Yan H; Xiao Z; Li W; Zhang J; Tang Q; Hu K; Koeffler HP; Wang J; Yin D
Clin Cancer Res; 2015 Oct; 21(19):4420-30. PubMed ID: 26059188
[TBL] [Abstract][Full Text] [Related]
8. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.
Li M; Zhang L; Ge C; Chen L; Fang T; Li H; Tian H; Liu J; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
Oncotarget; 2015 Sep; 6(28):25149-60. PubMed ID: 26327240
[TBL] [Abstract][Full Text] [Related]
9. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
[TBL] [Abstract][Full Text] [Related]
10. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCC.
Blukacz L; Nuciforo S; Fucile G; Trulsson F; Duthaler U; Wieland S; Heim MH
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38696353
[TBL] [Abstract][Full Text] [Related]
12. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
[TBL] [Abstract][Full Text] [Related]
13. NRF2/ABCB1-mediated efflux and PARP1-mediated dampening of DNA damage contribute to doxorubicin resistance in chronic hypoxic HepG2 cells.
Xia X; Wang Q; Ye T; Liu Y; Liu D; Song S; Zheng C
Fundam Clin Pharmacol; 2020 Feb; 34(1):41-50. PubMed ID: 31420991
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein.
Yang JQ; Pan GD; Chu GP; Liu Z; Liu Q; Xiao Y; Yuan L
World J Gastroenterol; 2008 Sep; 14(36):5564-9; discussion 5568. PubMed ID: 18810776
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
[TBL] [Abstract][Full Text] [Related]
16. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
17. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus X Protein Stimulates Proliferation, Wound Closure and Inhibits Apoptosis of HuH-7 Cells via CDC42.
Xu Y; Qi Y; Luo J; Yang J; Xie Q; Deng C; Su N; Wei W; Shi D; Xu F; Li X; Xu P
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282856
[TBL] [Abstract][Full Text] [Related]
19. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
20. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma.
Liu X; Zhang Y; Wang P; Wang H; Su H; Zhou X; Zhang L
Med Sci Monit; 2016 Jul; 22():2492-500. PubMed ID: 27421245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
